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Sickle cell disease (SCD) is a well known hemoglobinopathy with usual manifestations including anemia, hyperbilirubinemia, and
vasoocclusive complications. Despite presence of mild splenomegaly in early phase of the disease, lymphadenopathy is not an
often finding of SCD. We introduce an undiagnosed case of SCD who presented in third decade of his life with multiple cervical
lymphadenopathies and mild splenomegaly persistent for about five years. Histopathologic examination of the resected lymph
nodes showed expansion of the mantle cell layers of secondary follicles as well as several monomorphic mantle cell nodules. To
rule out possibility of a malignant process involving lymph nodes, an immunohistochemical panel was ordered which was in favor
of benign mantle cell hyperplasia. Immunoglobulin gene rearrangement study showed no clonal bands and confirmed benign
nature of the process. Respecting mild abnormalities on Complete Blood Count, peripheral blood smear was reviewed revealing
some typical sickle red blood cells as well as rare nucleated red blood cells. Solubility test for hemoglobin (HB) S was positive.
Hemoglobin electrophoresis confirmed diagnosis of homozygous HbS disease.
1. Introduction
Sickle cell disease (SCD) is an important hereditary hemoglo-
binopathy which affects more than 300000 annual births
worldwide mostly in low- and middle- income countries [1].
Its usual clinical manifestations include anemia, hyper-
bilirubinemia, and vasoocclusive complications [2]. The
patients experience some episodes of painful crisis resulting
from acute vasoocclusive pain due to entrapment of erythro-
cytes and leucocytes in the microcirculation [3].
While peripheral blood smear shows anemia associated
with presence of some sickle red blood cells (RBC), target
cells, and a few nucleated RBCs, bone marrow is hyper-
plastic because of compensatory hyperplasia of erythroid
precursors. Mild splenomegaly is seen during childhood, in
early phase of disease. Thereafter, progressive shrinkage of
the spleen due to continuous scarring occurs by adolescence
or early adulthood, a process called autosplenectomy [4].
Premature mortality occurs due to the complications of this
disease, especially cardiopulmonary organ dysfunction and
chronic kidney injury [5].
This article presents a 22-year-old boy newly diagnosed
with SCD who had cervical lymphadenopathy as an atypical
sign.
2. Case Presentation
A 22-year-old male presented with persistent multiple cer-
vical lymphadenopathy that had gradually developed in
size, mild splenomegaly, and several small lymph nodes in
perisplenic area for about five years. He had past history of
episodes of painful crisis in upper and lower limb bones since
childhood which resolved by analgesic but he never sought
medical treatment.
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Figure 1: Sections from an enlarged cervical lymph node. (a) Hematoxylin and Eosin staining. (b)–(f) Immunohistochemical staining for
CD20 (b), CD5 (c), IgD (d), Bcl-2 (e), and CD43 (f).
Due to persistent lymphadenopathy, splenomegaly, and
clinical suspicion of lymphoma, the largest cervical lymph
node measuring 2.5 × 1.5 × 1 cm was excised with initial
pathologic report of reactive follicular hyperplasia. It was
referred to our center for consultation. Lymph node showed
well preserved architecture containing secondary follicles
with pale staining germinal centers (GCs) surrounded by
dark staining layer of mantle cells. Mantle cell proliferation
resulting in broad and expansive mantle zone layer was
evident in some of the follicles.
Several monomorphic nodules composed of small sized
lymphocytes without germinal center were also notedmainly
in cortical region of the lymph node. Interfollicular region
was unremarkable (Figure 1(a)). No invagination of mantle
layer inside germinal centers and transformation of the layer
were identified.
On closer inspection, the nodules were composedmainly
of small sized lymphocytes with round to very slightly
indented nuclei and scant amount of cytoplasm.
Several congested capillaries and venules containing
deformed RBCs with a few typical sickle cells were also noted
in the sections after reviewing.
The main differential diagnoses were mantle zone hyper-
plasia, early stage of mantle cell hyperplasia, or other low
grade lymphomas. Therefore, immune histochemistry (IHC)
was done to determine true nature of the process. Briefly
after quenching of endogenous peroxidases and heat induced
antigen retrieval, sections were incubated with mouse mono-
clonal antibodies against CD20, Ki67, Bcl-2, andCD43 (1/300,
predilute, and 1/80, resp.; Dako Corp, Carpinteria, CA, USA),
mouse monoclonal antibodies against CD3, CD5, and CD23
(1/100, 1/5, and predilute, resp.; Novocastra Lab. Ltd. UK),
rabbit polyclonal antibodies against Immunoglobin (Ig) D,
IgM, IgG, and Kappa and Lambda light chains (1/3.5, 1/5000,
1/14000, 1/10000, and 1/10000, resp.; Dako Corp, Carpin-
teria, CA, USA), and rabbit monoclonal antibody against
Cyclin D1 (1/80; Dako Corp, Carpinteria, CA, USA). Bound
primary antibodies were reacted with secondary antibodies
conjugated with horse radish peroxidase. Visualization of
the complexes was accomplished with DAB as chromogen.
Sections were also lightly stained with Mayer’s hematoxylin.
Hyperplastic follicles, expanded mantle zone layers, and the
monomorphic nodules were strongly positive for CD20,
CD19, and Pax-5. Immunostaining with CD3 highlighted
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Table 1: Viral studies and serum immunoglobulin level on admis-
sion time.
Laboratory parameters On admission
VCA-IgG for EBV Positive
VCA-IgM for EBV Negative
Monospot test for EBV Negative
HBS antigen Negative
HBV IgG Negative
HCV IgG Negative
HIV IgG Negative
CMV IgM 0.7 IU
CMV IgG 1.5 IU
IgG serum level (gr/dL) 2
IgM serum level (gr/dL) 0.25
IgA serum level (gr/dL) 0.30
interfollicular T-cell areas which were unremarkable. Ki67
staining showed high proliferation activity confined to the
GCs whereas the areas outside the GCs and the monomor-
phic B-cell nodules had low proliferation activity (<5%). Bcl-
2 was not detected in GCs. Mantle cell layer of the follicles
and the monomorphic B-cell nodules were diffusely positive
for IgD and Bcl-2 whereas positivity for CD23 was weak
and scattered. Reaction for IgM was also weakly positive
(Figures 1(d) and 1(e)). Immunostaining for CD5, CD43,
and Cyclin D1 was negative in both mantle cell layer of the
hyperplastic follicles and the B-cell nodules (Figures 1(c)
and 1(f)). Immunohistochemical tests for Kappa and Lambda
light chain restriction were inconclusive.
To evaluate the clonality of the lymphoid population,
immunoglobulin heavy chain gene rearrangement study
was performed on DNA, extracted from 10 five-micron-
thick sections of FFPE tissue, using proteinase K incubation
method followed by phenol-chloroform extraction protocol.
Conventional PCR for Ig gene rearrangement study was
performed using BIOMED-2 concerted action primers from
InVivoScribe Technologies (San Diego, CA) based on man-
ufacturer’s instructions. DNA integrity was controlled using
three primer sets for amplification of beta-globin gene with
PCR products of 110 bp to 400 bp.
PCR products were detected and analysed using poly-
acrylamide gel 6% and heteroduplex assay. In the presence of
beta-globin gene amplification, conventional PCR for Ig gene
rearrangement study did not yield any clonal bands.
Even though lymphadenopathy in this patient was a
long lasting sign, a comprehensive investigation for possible
infectious etiologies was done and no cause for this lym-
phadenopathy was found (Table 1). Also, no morphological
change indicative for specific infectious etiologies was found
in lymph node tissue sections.
Searching for probable causes, all data were reviewed
which showed anemia with mild leukocytosis in Complete
Blood Count (CBC). Table 2 shows the results of hematologic
studies. Also mild splenomegaly appeared in abdominal
sonography.
Regarding leukocytosis, peripheral blood smear was pre-
pared which revealed presence of some typical sickle RBCs,
Table 2: Results of hematologic studies.
Laboratory parameters On admission
Hemoglobin (g/dL) 11.2
Red blood cell (count/mm3) 4220000
Mean corpuscular volume (fL) 84.6
White blood cell (count/mm3) 13100
Neutrophil (%) 61
Lymphocyte (%) 25
Mixed (%) 14
Platelet (count/mm3) 259000
Prothrombin time (sec) 13
International normalized ratio 1
Partial thromboplastin time (sec) 35
Erythrocyte sedimentation rate (mm/hr) 5
Blood urea nitrogen (mg%) 23
Creatinine (mg%) 1.2
Total bilirubin (mg%) 3.2
Direct bilirubin (mg%) 0.3
C-reactive protein (mg/dL) Negative
a few target cells, and rare nucleated RBCs. No atypical
lymphoma or leukemia cell was identified. Solubility test
for hemoglobin (Hb) S was strongly positive and Hb elec-
trophoresis showed homozygous HbS disease with >80%
HbS, >10% HbF, and <5% Hb A1.
3. Discussion
Our report describes a young male who presented with
persistent multiple cervical lymphadenopathy and mild
splenomegaly for about 5 years. Histomorphologic review
of the resected lymph node showed well defined secondary
follicles as well as several monomorphic nodules composed
of monotonous population of small lymphocytes mainly
with regular round nuclei, inconspicuous nucleoli, and scant
cytoplasm.
Expanded mantle zone of secondary follicles and the
nodular proliferations showed positive reaction for CD20,
IgD, Bcl-2, IgM (weak), and CD23 (scattered) along with
negative immunostaining for CD3, CD5, CD43, and Cyclin
D1. This pattern of IHC profile is characteristic of benign
mantle cells which are responsible for proliferation and
expansion producing broadmantle cell layers andmantle cell
nodules in this case. Reactive follicular hyperplasia of any
other cause, reactive follicles with transformation of germinal
centers, marginal zone hyperplasia, and early stage of mantle
cell lymphoma are the main differential diagnoses of such
finding.
It is acceptable that mild lymphadenopathy be seen in
SCD due to abnormal shape and sickling of RBCs occurring
in various hypoxic conditions. Patients with autosplenectomy
are susceptible to infectious diseases that can cause lym-
phadenopathy and lymph node enlargement [6]. Also, it is
found that the children with SCD have increased lymphoid
tissue in the head and neck region,manifested by prominence
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of the adenoids and palatine tonsils, in proportion to general
population [7]. However, initial presentation of SCD in
third decade of life with persistent lymphadenopathy due to
mantle cell hyperplasia has not been reported yet. Mantle cell
hyperplasia is a rare reactive change seen in lymph node. It
has been only rarely reported so far and the main causes of it
are not well known [8].
Lymphadenopathy in this case is most likely due to
the disease process itself. By considering persistence of the
problem for about 5 years and absence of pertinent clinical
and paraclinical data denoting specific etiologic factors,
lymphadenopathy caused by mantle cell hyperplasia can
be considered a finding directly related to SCD and the
first presentation of the disease in this case. Besides these,
mantel cell hyperplasia is not a usual well known response
to microbial agents. We proposed that sequestration of
node sinuses by sickle cells without vascular occlusion and
secondary infarction may elicit an immunologic response
leading to this peculiar lymphoid hyperplasia. Also, chronic
nonspecific immune stimulation and adenitismay be another
explanation for persistent lymphnode enlargement leading to
initial diagnosis of SCD.
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